Dr. Nancy Padilla Coreano's lab at the University of Florida focuses on understanding how the brain determines when we compete or cooperate in social situations. By studying neural mechanisms in mice, the lab aims to uncover how specific brain regions influence these behaviors, which can shed light on social difficulties seen in disorders like autism and schizophrenia. The research integrates advanced technologies to explore the connections between brain activity and social behaviors, aiming to enhance treatment strategies.

The research lab led by Dr. Benzi M Kluger focuses on improving the quality of life for individuals affected by Parkinson's Disease (PD) and Lewy Body Dementia (LBD) through innovative palliative care methods. The lab is exploring community-based interventions that combine palliative care with neurology to address both medical and psychosocial needs of patients and their caregivers. Their goal is to enhance care delivery in the community and provide better support mechanisms through online learning communities and social support networks.

Dr. Paul T. Kotzbauer's lab focuses on understanding how protein aggregation impacts cognitive decline in Parkinson's disease. They investigate how the buildup of certain proteins in the brain, like alpha-synuclein, contributes to dementia and other cognitive deficits in patients with Parkinson's. By analyzing brain tissue from autopsy samples, the lab aims to uncover the relationship between these protein accumulations, neuronal degeneration, and cognitive functioning in patients.

Dr. Clemens R. Scherzer's lab at Yale University focuses on understanding how genetic factors contribute to the progression of Parkinson's disease, particularly in relation to cognitive decline and dementia. The research aims to identify specific genetic markers that can predict the risk of developing dementia in Parkinson's patients, which could change how we approach treatment and management of the disease. By analyzing data from a large number of patients over time, the lab seeks to improve clinical outcomes for individuals affected by Parkinson's disease.

Dr. Payal Patel's lab at the University of Washington investigates the links between HIV and cognitive health in young adults. The research focuses on understanding how myelin, a key component of brain white matter, may be affected in individuals living with HIV, even those who are virally suppressed. This work aims to identify risks for cognitive impairment and explore potential interventions to improve brain health.

Dr. Bindu Paul's lab at Johns Hopkins University is studying how hydrogen sulfide, a gas produced in the brain, protects against neurodegeneration, particularly in Alzheimer's disease. The team aims to uncover the specific molecules and pathways that are affected by hydrogen sulfide, which could lead to new therapies for age-related brain diseases. Their research combines molecular biology techniques with behavioral studies in mouse models to explore these protective mechanisms.

Dr. Jane S. Paulsen's lab focuses on understanding and improving the diagnosis of a genetic condition called CADASIL, which affects blood flow to the brain and can lead to dementia. The lab investigates how changes in the retina can provide insights into the progression of CADASIL and potentially other forms of vascular dementia. By using advanced imaging techniques, they aim to identify reliable biomarkers that can help in earlier diagnosis and treatment effectiveness in clinical trials.

Dr. Caroline Alayne Pearson's lab at Weill Medical College of Cornell University investigates how glucose transport impacts brain development and disorders. The lab focuses on understanding the role of a specific glucose transporter in neural progenitor cells and its relevance to conditions like GLUT1-Deficiency Syndrome. Through cutting-edge techniques, researchers study how changes in glucose regulation affect neural cell development and function.

Dr. Kevin Pelphrey's research lab at the University of Virginia focuses on improving the diagnosis of autism spectrum disorder (ASD), particularly for individuals who are diagnosed later in life. By combining qualitative and quantitative approaches, along with artificial intelligence, the lab aims to identify behavioral markers that can predict late diagnoses. Their work will lead to the creation of a new screening tool that can help provide timely support for individuals at risk of being misdiagnosed or undiagnosed.

Dr. Miguel A Perez-Pinzon's lab at the University of Miami focuses on understanding how ischemic preconditioning can protect the brain from stroke-related damage. They study the role of specific molecules like Brain-Derived Neurotrophic Factor (BDNF) and Resveratrol in improving brain function and synaptic health. The lab aims to uncover new therapeutic strategies to help patients recover cognitive function after a stroke and potentially benefit those with related conditions like Alzheimer's disease.

Dr. Jeiran Choupan's lab at the University of Southern California focuses on understanding the brain's perivascular spaces (PVS) and their role in aging and Alzheimer's disease (AD). This research aims to map the structure and diffusion properties of PVS in the brain, helping to uncover how they change with age and in conditions like AD. By using advanced imaging techniques, the lab hopes to develop resources that other researchers can use to study neurological disorders related to PVS dysfunction.

Dr. David C. Perry's research lab focuses on understanding and improving the diagnosis and prognosis of behavioral variant frontotemporal dementia (bvFTD), a type of early-onset dementia. The lab studies patients over time to uncover clinical and biological differences that could help predict how the disease progresses. By combining neurological examinations, cognitive tests, and neuroimaging data, the goal is to enhance accurate diagnoses and tailor clinical care for patients and their families.

Dr. Hemali Phatnani's lab at Columbia University Health Sciences focuses on understanding the mechanisms behind neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). The lab investigates how protein aggregation—especially that of TDP-43—can lead to damage in nerve cells and contributes to these diseases. They aim to uncover the physical and molecular changes that predispose certain cells to disease and develop new treatment strategies that could improve patient outcomes.

Dr. Giuseppina Pilloni's research lab at NYU focuses on innovating noninvasive brain stimulation techniques, specifically transcranial direct current stimulation (tDCS), to improve treatment for neuropsychiatric symptoms like depression. The lab aims to integrate heart rate variability (HRV) as a biomarker to tailor tDCS therapies, making them more personalized and effective. By utilizing telehealth technologies, they seek to enhance accessibility and scalability of mental health interventions.

Dr. Angus M Macnicol's lab at the University of Arkansas for Medical Sciences studies how the anterior pituitary gland adapts to changes in hormonal needs, especially relating to female fertility and aging. The lab focuses on the role of a protein called Musashi, which influences how pituitary cells change and function in response to bodily stress. By understanding these processes, the lab aims to find ways to improve fertility and treat hormone-related disorders.

Dr. Michael Platt's lab focuses on understanding how environmental stressors, like natural disasters, affect mental health and social behavior. Using the unique situation of free-ranging rhesus macaques impacted by a hurricane, the lab investigates the biological and social factors that contribute to resilience or vulnerability in response to stress. The findings could have important implications for improving mental health outcomes in humans by identifying protective factors from social connections.

Dr. Alexander Pollen's lab at UCSF focuses on understanding how human brains are uniquely adapted to challenges like aging and stress. They study dopaminergic neurons, which are critical for movement and mood, to see how they cope with age-related stressors compared to those in other primates. By combining modern techniques like CRISPR and machine learning with stem cell-derived organoids, the lab aims to uncover the genetic changes that contribute to human brain plasticity and vulnerability to disorders.

Dr. Franck Polleux's lab at Columbia University focuses on understanding the development and evolution of brain circuits, particularly how unique human features emerge at the molecular level. The lab investigates how specific proteins and genes influence the structure and function of neurons and synapses, which could reveal insights into the biology of human cognitive capabilities and disorders. Through their research, they aim to uncover the cellular mechanisms involved in brain development and their implications for neurodevelopmental and neurodegenerative diseases.

Dr. Nita A Limdi's lab focuses on improving healthcare through genomic medicine by implementing population genomic screening and a regional eConsult service to help identify genetic risks in patients. The lab seeks to integrate genomic testing into primary care, enabling better diagnosis and treatment of preventable conditions. By collaborating with community stakeholders, they aim to empower healthcare providers and improve patient outcomes across the Southeast region of the U.S.

Dr. Jennifer A. Kim's research lab focuses on tackling post-traumatic epilepsy, a condition impacting many individuals recovering from traumatic brain injuries. By leveraging advanced data analysis techniques, including machine learning and neuroimaging, the lab aims to develop automated tools for predicting who is at risk for developing epilepsy after injury. This work could significantly improve patient outcomes by enabling early interventions based on individual risk factors.